(Q35087048)

6 August 2017

1 reference

title

Veno-occlusive disease: cytokines, genetics, and haemostasis (English)

1 reference

6 August 2017

Jason A Coppell

1

1 reference

6 August 2017

Simon A Brown

series ordinal

2

1 reference

6 August 2017

David J Perry

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

63-70

1 reference

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Characterization of a reproducible rat model of hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Avoiding hepatic veno-occlusive disease: what do we know and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Erythrocyte glutathione reductase polymorphism in a Sudanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Mutations in the glutathione synthetase gene cause 5-oxoprolinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Venocclusive disease of the liver: prospective study of US evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Glutathione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Parenteral glutamine protects hepatic function during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Glutathione defense in non-parenchymal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

The distribution, induction and isoenzyme profile of glutathione S-transferase and glutathione peroxidase in isolated rat liver parenchymal, Kupffer and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow trans

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Haemostatic and fibrinolytic responses to bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Increased plasma t-PA activity and urinary PGE2 after repeated oral administration of defibrotide to the rat and the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Protective effect of defibrotide on perfusion induced endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Defibrotide Protects Endothelial Cells, but not L929 Tumour Cells, from Tumour Necrosis Factor-α-mediated Cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Taming TNF: strategies to restrain this proinflammatory cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

Effects of N-acetylcysteine in endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900002-X

7 January 2021

10.1016/S0268-960X(03)00002-X

Identifiers

DOI

1 reference

6 August 2017

1 reference